Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Browsing: World News
Jubilant Biosys and Sanofi Deutschland GmbH Enter Into a Strategic Alliance Focusing on Metabolic Disorders Therapeutic Area
Collaboration Aimed at Discovery and Development of Small Molecule Inhibitors Through to Phase I Proof of Mechanism in Metabolic Disorders…
honor 5X Debuts at International CES 2016
The wait is over for Internet-minded millennials that demand a smartphone purpose-built for their lifestyles. The U.S. debut of honor…
Report on TOSHIBA VISION Times Square & New York Times Square New Year’s Eve Celebration 2016 Event
Toshiba Corp. is the official sponsor of the Times Square New Year’s Eve Celebration, the biggest countdown event in the…
On December 27, 2015, Air China announced at a ceremony held at T3 of Beijing Capital International Airport that it…
Changzhou Comprehensive Free Trade Zone to Provide End-to-End Full Service Customs Clearance Platform
Changzhou Comprehensive Free Trade Zone recently passed inspection tests conducted by ten government agencies including Nanjing Customs and received all…
Huawei Fellow Dr. Wen Tong: New Theories and Models Inspired Huawei’s Revolutionary Application-driven Network
Huawei Fellow Dr. Wen Tong announced today that the company’s revolutionary Application-driven Network (ADN) was inspired by three information consumption…
Metsa Wood’s Plan B for Germany: Constructing the Reichstag from Wood
In the Plan B project, Metsa Wood explores the possibilities of wood by planning how to construct iconic buildings out…
FC Schalke 04 Launches Online Shops for Fans in Asia-Pacific
Royal Blues implement next project in long-term internationalisation plan
Rediff Announces 2015 Year End Happiness Sale
Rediff.com India Pvt. Ltd (NASDAQ: REDF) (“Rediff” or “the Company”), an India-based internet company which delivers digital content and ecommerce…
United Laboratories Inc. and Debiopharm International SA Announce the Launch of Pamorelin® LA in the Philippines
Pamorelin(R) one-, three- and six-month dosing option now available to patients in the Philippines.